Navigation Links
Patheon to Showcase High Potency Capabilities at Upcoming Tradeshows
Date:4/12/2013

(PRWEB) April 12, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will showcase its high potency capabilities at the 2013 BIO International Convention in Chicago, Illinois on April 22 – 25, 2013, as well as at INTERPHEX 2013 in New York City on April 23 – 25, 2013.

High potent compounds are in the most stringently regulated categories in the industry, so strict adherence to the regulations and progressive modernization is required to manage the associated risks. Patheon has invested significant resources and maintains specialized teams to meet customer and regulatory standards, while maintaining a longstanding commitment to quality and safety. The company’s unique approach allows for high potent compounds to be taken quickly and cost-effectively from formulation to large-scale manufacturing with consistent, proven quality.

Patheon representatives will be available to discuss the company’s high potency capabilities, along with several other key service offerings, at the BIO International Convention (Booth #2370) and INTERPHEX (Booth #4123). More information is available at http://www.patheon.com/Knowledge-Library/Events.aspx.

To schedule a meeting in advance send an email to events(at)patheon(dot)com. All media inquiries or interview requests should be directed to media(at)patheon(dot)com.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule tech
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
2. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
3. Patheon to Present at Informex USA
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. Patheon to Present at 2013 DCAT Week
6. Patheon to Present New Updates in Drug Formulation and Bioavailability
7. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
8. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... The report, "Synthetic Biology ... Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, ... Bioremediation) - Global Forecast to 2018", analyses ... opportunities, and challenges. , Browse 99 market ... 185 pages and in-depth TOC of the ...
(Date:11/21/2014)... Arkansas (PRWEB) November 20, 2014 ... Pinnacle Ozone Solutions, LLC (Pinnacle), and PCI, Inc., ... announced that they have been selected to provide ... of Fayetteville, Arkansas Paul R. Noland Wastewater Treatment. ... BlueInGreen’s patented HyDOZ® gas dissolution technology, ...
(Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... China Sodium Ferrocyanide Industry” is a professional and ... it provides Sodium ferrocyanide information, like its ... well as industry overview. This report covers the ... well as global (such as the US, Europe, ...
(Date:11/21/2014)... DIEGO , Nov. 20, 2014 ... has been dosed in its Phase 1 trial ... cisplatin for the treatment of malignant pleural mesothelioma ... Group is conducting clinical trials on ADI-PEG 20, ... agents, for the treatment of several other indications, ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
... Wis. A professor who has worked for the ... lifespan of rhesus monkeys was featured in the MIT Technology ... colony of 78 monkeys at the University of Wisconsin-Madison, has ... the lifespans of mice. But while testing on mice is ...
... can be profitable after all. Last week, the leading ... hit the elusive goal of every startup organization: profitability. ... contacts for free, LinkedIn last summer introduced premium services, ... Acceptance of these premium offerings has exceeded expectations of ...
... checked in with Wisconsin secretary of commerce Mary Burke on some ... Innovates conference in Milwaukee, encouraging companies such as Abbott Laboratories ... WTN: Innovation is a word that comes up a lot in ... , , Burke Burke: I come ...
Cached Biology Technology:Free can be profitable 2Commerce secretary Mary Burke on innovation, expansion and BIO 2Commerce secretary Mary Burke on innovation, expansion and BIO 3
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... history at NJIT and a former Guggenheim Fellow, has ... to edit a volume of the correspondence of James ... for his biography of Samuel Johnson. Sher,s ... century Scotland. Yale University Press will publish the book ...
... 5, 2009 It,s not uncommon for students to consume ... the night. "Energy drinks are the coffee of a new ... Montral health and nutrition think-tank. "These drinks are made up ... on health." According to a 2008 report by Agriculture ...
... A team of researchers are reporting the ongoing emergence of ... a new species of wasp--in the February 6 issue of ... of Notre Dame biologist, and his colleagues say the introduction ... have changed the behavior of a fruit fly, leading to ...
Cached Biology News:Researchers observe evolution chain reaction 2
... 2 real-time PCR detection system uses a ... (470-505 nm) and two photomultiplier tubes for ... Opticon 2 system is built on an ... thermal gradient feature. This item includes the ...
... SYBR Green I or FAM in the ... in the second channel including TET, ... multitude of applications such as RT-qPCR and ... precision thermal control and a temperature gradient ...
Fingerprinting II dimensioning techniques is an optional module that adds principal component analysis, multidimensional scaling, discriminant analysis and MANOVA, and self-organizing maps to the Fin...
...
Biology Products: